Gleason's histologic grading as clinical prognostic marker in patients with advanced prostatic carcinoma.
We have found that the Gleason's histologic grading system is a good clinical marker to predict long-term response and prognosis in symptomatic Stage D-2 adenocarcinoma of the prostate. In this retrospective study, 56 cases were reviewed and correlated with bone scan, acid phosphatase, and symptomatology following bilateral orchiectomy.
Schwartz
C B
CB
Department of Urology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.
Bekirov
H
H
Melman
A
A
D000230:Adenocarcinoma / Q000473:pathology*; D000368:Aged; D006801:Humans; D008297:Male; D009367:Neoplasm Staging / Q000379:methods; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000473:pathology*; D012189:Retrospective Studies